Interestingly, the
majority (>55%) of such service providers firms are based in Europe,
claims Roots Analysis




Repurposing
of marketed / shelved / pipeline candidates for the treatment of diseases
(different from original target indications) has emerged as a viable business
strategy. The rising popularity of this approach can further be attributed to
various benefits, such as reduced development timelines, decreased investments
and relatively higher success rates (considering that the safety profiles of
such candidates have already been established).





To order this 250+ page report, which features 100+ figures
and 140+ tables, please visit this - https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html





The
USD 1.2 billion (by 2030) financial opportunity within the drug repurposing
service providers market has been analyzed across the following segments:


§ Type
of Repurposing Approaches


§ Disease-centric
approach


§ Target-centric
approach


§ Drug-centric
approach


§ Therapeutic
Area


§ Same
Therapeutic Area


§ Different
Therapeutic Area


§ Type
of Drug Molecule


§ Biologics


§ Small
Molecule


§ Key
Geographical Region


§ North
America


§ Europe


§ Asia-Pacific






The Drug
Repurposing Service Providers Market, 2020-2030 report features the following companies, which we
identified to be key players in this domain:


§ Auxillis Pharma


§ ChemBio Discovery Solutions


§ Excelra


§ GVK Bio


§ Iris Pharma


§ Lantern Pharma


§ PanXome


§ Pharmacelera


§ Physiogenex


§ Smart Pharma


§ Socium


§ SOM Biotech





To Request for sample report - https://www.rootsanalysis.com/reports/drug-repurposing-service-provides/request-sample.html





Table of Contents





1. Preface



2. Executive Summary



3. Introduction






4. Market Landscape






5. Role of Non-Profit / Academic Organizations





6. Company Profiles






7. Partnerships






8. Big Pharma Initiatives






9. Case Study: Discontinued Drug Development Programs






10. Cost Saving Analysis






11. Market Forecast and Opportunity Analysis






12. Covid-19 Impact on
Drug Repurposing Service Providers Market






13. Recent Advancements and Trends in Outsourcing of Drug
Repurposing





14. Interview Transcripts





15. Appendix 1: List of Potential Drug-Indication Candidates for
Drug Repurposing





16. Appendix 2: Tabulated Data





17. Appendix 3: List of Companies and Organizations





To
purchase a copy, please visit https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html





Other Recent Offerings


1.
Viral
Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4th
Edition), 2021-2030


2.
Global
T-Cell (CAR-T, TCR, and TIL) Therapies Market (5th Edition), 2020-2030


3.
Oncolytic
Virus Therapy Market: Pipeline Review, Developer Landscape and Competitive
Insights, 2020-2030





About Roots Analysis


Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com





Contact Information


Roots
Analysis Private Limited


Gaurav Chaudhary


+1 (415) 800 3415


ben.johnson@rootsanalysis.com


Facebook - https://www.facebook.com/RootsAnalysis


LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/


Twitter - https://twitter.com/RootsAnalysis